Neoantigen Discovery Pipeline for Oncology

In an R&D and clinical trial setting, we assisted in the identification and prioritization of cancer neoantigen for targeted immunotherapy. 

We developed an AI-driven solution that seamlessly integrates DNA and RNA sequencing via a robust NGS variant calling pipeline. Using machine learning to prioritize neoantigens for cancer therapies, we created a scalable and interactive hybrid cloud data analysis and visualization solution.

In an R&D and clinical trial setting, we assisted in the identification and prioritization of cancer neoantigen for targeted immunotherapy. 

We developed an AI-driven solution that seamlessly integrates DNA and RNA sequencing via a robust NGS variant calling pipeline. Using machine learning to prioritize neoantigens for cancer therapies, we created a scalable and interactive hybrid cloud data analysis and visualization solution.

Value for the client:

  • Tailor-made pipeline for identifying neoantigen candidates
  • Complete integration with laboratory product workflow
  • Reviewable and auditable
  • GDPR & GAMP 5 compliant

No items found.